[HTML][HTML] CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis
…, E Gane, J Taubel, J Kao, M Fontana… - … England Journal of …, 2021 - Mass Medical Soc
Background Transthyretin amyloidosis, also called ATTR amyloidosis, is a life-threatening
disease characterized by progressive accumulation of misfolded transthyretin (TTR) protein in …
disease characterized by progressive accumulation of misfolded transthyretin (TTR) protein in …
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis
…, AWJM Glaudemans, T Rezk, M Fontana… - Circulation, 2016 - Am Heart Assoc
Background— Cardiac transthyretin (ATTR) amyloidosis is a progressive and fatal
cardiomyopathy for which several promising therapies are in development. The diagnosis is …
cardiomyopathy for which several promising therapies are in development. The diagnosis is …
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
…, T Damy, U Eriksson, M Fontana… - European heart …, 2021 - academic.oup.com
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine rollout has coincided
with the spread of variants of concern. We investigated whether single-dose vaccination, …
with the spread of variants of concern. We investigated whether single-dose vaccination, …
Magnetic resonance in transthyretin cardiac amyloidosis
Background : Cardiac transthyretin amyloidosis (ATTR) is an increasingly recognized cause
of heart failure. Cardiac magnetic resonance (CMR), with late gadolinium enhancement (…
of heart failure. Cardiac magnetic resonance (CMR), with late gadolinium enhancement (…
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
…, T Cutino-Moguel, M Andiapen, M Fontana… - Science …, 2020 - science.org
Understanding the nature of immunity following mild/asymptomatic infection with SARS-CoV-2
is crucial to controlling the pandemic. We analyzed T cell and neutralizing antibody …
is crucial to controlling the pandemic. We analyzed T cell and neutralizing antibody …
Immune boosting by B. 1.1. 529 (Omicron) depends on previous SARS-CoV-2 exposure
…, MO Diniz, A Ellis, K Feehan, M Finlay, M Fontana… - Science, 2022 - science.org
The Omicron, or Pango lineage B.1.1.529, variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) carries multiple spike mutations with high transmissibility and …
coronavirus 2 (SARS-CoV-2) carries multiple spike mutations with high transmissibility and …
Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis
…, SK Piechnik, SM Banypersad, M Fontana… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives : This study sought to explore the potential role of noncontrast myocardial T1
mapping for detection of cardiac involvement in patients with primary amyloid light-chain (AL) …
mapping for detection of cardiac involvement in patients with primary amyloid light-chain (AL) …
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance
Background Troponin elevation is common in hospitalized COVID-19 patients, but underlying
aetiologies are ill-defined. We used multi-parametric cardiovascular magnetic resonance (…
aetiologies are ill-defined. We used multi-parametric cardiovascular magnetic resonance (…
Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis
M Fontana, S Pica, P Reant, A Abdel-Gadir, TA Treibel… - Circulation, 2015 - Am Heart Assoc
Background— The prognosis and treatment of the 2 main types of cardiac amyloidosis,
immunoglobulin light chain (AL) and transthyretin (ATTR) amyloidosis, are substantially …
immunoglobulin light chain (AL) and transthyretin (ATTR) amyloidosis, are substantially …